World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
130
Citations
62787
World Ranking
2496
National Ranking
48

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Per Ljungman is affiliated with Karolinska University Hospital in Sweden and has an extensive research portfolio focused primarily on medicine, with particular attention to infectious diseases, hematology, oncology, epidemiology, and immunology. Their work spans a large number of publications centered on hematopoietic stem cell transplantation and related complications, infectious disease outcomes, and clinical impacts of COVID-19.

The researcher has contributed to several recent papers, including:

  • COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey (2021, Leukemia)
  • The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy (2020, Bone Marrow Transplantation)

Per Ljungman often collaborates with other researchers who frequently co-author their work. Key collaborators include Rafael de la Cámara, Małgorzata Mikulska, Jan Styczyński, Simone Cesaro, and Gloria Tridello.

Their publications are frequently found in several specialized venues, including:

  • Bone Marrow Transplantation
  • Blood
  • Leukemia
  • Frontiers in Immunology
  • Clinical Infectious Diseases

The main topics explored in Per Ljungman's research involve hematopoietic stem cell transplantation, COVID-19 clinical research studies, cytomegalovirus and herpesvirus research, SARS-CoV-2 and COVID-19 research, CAR-T cell therapy research, herpesvirus infections and treatments, and the healthcare impacts of COVID-19.

Their prominent subfields include infectious diseases, hematology, oncology, epidemiology, and immunology, highlighting a multidisciplinary approach to understanding and managing complex clinical scenarios related to transplantation and infectious complications.

Best Publications

  • 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

    Lorry G. Rubin;Myron J. Levin;Per Ljungman;E. Graham Davies

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients

    Per Ljungman;Paul Griffiths;Carlos Paya

  • Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

    Francisco M Marty;Per Ljungman;Roy F Chemaly;Johan Maertens

  • Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

    Lorry G. Rubin;Myron J. Levin;Per Ljungman;Per Ljungman;E. Graham Davies

  • Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.

    Per Ljungman;Per Ljungman;Michael Boeckh;Michael Boeckh;Hans H Hirsch;Filip Josephson

  • Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

    Per Ljungman;Morgan Hakki;Michael Boeckh;Michael Boeckh

  • How we treat cytomegalovirus in hematopoietic cell transplant recipients

    Michael Boeckh;Per Ljungman

  • Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.

    Socié G;Henry-Amar M;Bacigalupo A;Hows J

  • Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.

    K. Le Blanc;H. Samuelsson;B. Gustafsson;M. Remberger

  • NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRS

    Vivien Béziat;Lisa L. Liu;Jenny-Ann Malmberg;Martin A. Ivarsson

  • Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

    BB Bjorkstrand;P Ljungman;H Svensson;J Hermans

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

  • A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

    O Ringden;T Ruutu;M Remberger;J Nikoskelainen

  • Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.

    Åsa Gustafsson;Victor Levitsky;Jie Zhi Zou;Teresa Frisan

  • Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

    G. Gahrton;H. Svensson;M. Cavo;J. Apperley

  • Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

    Dick van Rhenen;Hans Gulliksson;Jean-Pierre Cazenave;Derwood Pamphilon

  • Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.

    J Styczynski;P Reusser;H Einsele;R de la Camara

  • Allogeneic bone marrow transplantation in multiple myeloma

    G Gahrton;S Tura;P Ljungman;C Belanger

  • Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

    Pierre Reusser;Hermann Einsele;John Lee;Liisa Volin

  • Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma

    G Gahrton;S Tura;P Ljungman;J Bladé

Frequent Co-Authors

Olle Ringdén
Olle Ringdén Karolinska Institute
Catherine Cordonnier
Catherine Cordonnier Paris-Est Créteil University
Gérard Socié
Gérard Socié Université Paris Cité
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Arnon Nagler
Arnon Nagler Sheba Medical Center
Jakob Passweg
Jakob Passweg University Hospital of Basel
Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Myriam Labopin
Myriam Labopin Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their medical and healthcare careers in the USA, a wide range of online degree programs are now available. Choosing a program with the right accreditation is crucial for advancing in the healthcare field. It is important to consider which online healthcare degree programs are recognized for their accreditation by cahme? as these credentials can have a direct impact on employment and advancement opportunities.

If you are already a registered nurse seeking to earn a Bachelor of Science in Nursing, there are best online rn to bsn programs without clinical requirements that offer a flexible pathway to continue your education without hands-on clinical components. For those aiming for advanced practice or leadership positions, consider exploring accelerated dnp programs to complete your Doctor of Nursing Practice in less time.

Cost can also be a major concern for many students. Fortunately, there are options for the cheapest dnp program, allowing you to pursue advanced nursing education without accumulating significant debt. Online pathways make it easier than ever to balance work, study, and personal commitments while advancing your healthcare career.

Best Scientists Citing Per Ljungman

Trending Scientists